Sign in
WithdrawnNo phase

Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection

Key facts

Who runs it
University of Texas Southwestern Medical Center
Where
Dallas, United StatesSee the site
Trial code
Status
Withdrawn
Started
1 Feb 2019
Ended
1 Jun 2024
Type of study
Observational, 3 groups
Record updated
26 February 2019
Why it stopped
Withdrawing study from PRS-this is not an actual clinical trial

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Ankle Brachial Index (ABI) ≥ 0.5 (bedside ABI is acceptable for screening purposes as the formal imaging ABI may not be resulted prior to surgery); One or more chronic lower extremity wounds that are located in the ankle area or below that has persisted a minimum of 30 days prior to the Screening visit, however, only one wound per subject will be included; Ulcer grade I or II, Stage A-D, according to University of Texas Wound Classification System; ≥21 years of age or older; Diagnosis of diabetes mellitus

Who cannot take part

  • • Subject has major immunodeficiency; Subject is human immunodeficiency virus (HIV)+; Subject has untreated osteomyelitis; Subject has active cellulitis; Subject has active charcot; Is pregnant or plans to become pregnant; Is nursing or actively lactating; Developmental disability/significant psychological disorder that in the opinion of the investigator could impair the subject's ability to provide informed consent, participate in the study protocol or record study measures, including untreated schizophrenia, bipolar disorder and psychiatric hospitalization within the last 2 years; Active alcohol or substance abuse in the opinion of the investigator that could impair the subject's ability to provide informed consent, participate in the study protocol or record study materials

Where in United States

  • UT Southwestern Medical Center at DallasDallas, United States

About the trial

What the trial wants to find out

The investigators plan to enroll up to 750 subjects over the course of 5 years. Study duration will be 2 visits over 7 days (+/-3). Participants will be consented and undergo baseline procedures. Participants will be grouped into 1 of 3 groups, based on infection and antibiotic status at screening. Debridement will be performed per standard of care and collection of tissue will be taken from this discarded tissue. A blood draw will be performed at each of these two visits as well. This is for research purposes only. All other data will be obtained from the electronic medical record. All standard of care except for the blood draws.

The 3 groups in the trial

  • Cohort 1

    Cohort 1: clinically uninfected (1A and 1C) ulcers.

  • Cohort 2

    Cohort 2: clinically infected (redness, edema, induration, heat, exudate, tenderness/pain (1B and 1D)) with no recent antibiotic therapy (within 28 days)

  • Cohort 3

    Cohort 3: clinically infected (redness, edema, induration, heat, exudate, tenderness/pain (1B and 1D)) on antibiotic therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
26 February 2019